BR112012021995A2 - ''composições e métodos para a produção bacteriana de condroitina'' - Google Patents

''composições e métodos para a produção bacteriana de condroitina''

Info

Publication number
BR112012021995A2
BR112012021995A2 BR112012021995A BR112012021995A BR112012021995A2 BR 112012021995 A2 BR112012021995 A2 BR 112012021995A2 BR 112012021995 A BR112012021995 A BR 112012021995A BR 112012021995 A BR112012021995 A BR 112012021995A BR 112012021995 A2 BR112012021995 A2 BR 112012021995A2
Authority
BR
Brazil
Prior art keywords
compositions
methods
chondroitin production
bacterial
bacterial chondroitin
Prior art date
Application number
BR112012021995A
Other languages
English (en)
Other versions
BR112012021995A8 (pt
Inventor
Craig A Weaver
Daniel H Doherty
Kentaro Miyamoto
Toshikazu Minamisawa
Original Assignee
Dsm Ip Assets Bv
Seikagaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv, Seikagaku Kogyo Co Ltd filed Critical Dsm Ip Assets Bv
Publication of BR112012021995A2 publication Critical patent/BR112012021995A2/pt
Publication of BR112012021995A8 publication Critical patent/BR112012021995A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
BR112012021995A 2010-03-01 2011-03-01 Composição,célula hospedeira bacteriana não patogênica, método para a produção de um sulfato de condroitina,condroitina, composição e anticorpo ou fragmento de anticorpo BR112012021995A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30940710P 2010-03-01 2010-03-01
PCT/US2011/026748 WO2011109438A1 (en) 2010-03-01 2011-03-01 Compositions and methods for bacterial production of chondroitin

Publications (2)

Publication Number Publication Date
BR112012021995A2 true BR112012021995A2 (pt) 2015-10-06
BR112012021995A8 BR112012021995A8 (pt) 2018-01-02

Family

ID=44542545

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012021995A BR112012021995A8 (pt) 2010-03-01 2011-03-01 Composição,célula hospedeira bacteriana não patogênica, método para a produção de um sulfato de condroitina,condroitina, composição e anticorpo ou fragmento de anticorpo

Country Status (8)

Country Link
US (2) US8697398B2 (pt)
EP (1) EP2542686B1 (pt)
JP (1) JP5875531B2 (pt)
KR (1) KR101848102B1 (pt)
CN (1) CN102869782B (pt)
BR (1) BR112012021995A8 (pt)
ES (1) ES2661593T3 (pt)
WO (1) WO2011109438A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2661593T3 (es) 2010-03-01 2018-04-02 Seikagaku Corporation Composiciones y métodos para producción bacteriana de condroitina
KR101855062B1 (ko) * 2010-07-09 2018-05-09 그노시스 에스.피.에이. 콘드로이틴의 생물공학적 생산
WO2013172154A1 (ja) * 2012-05-17 2013-11-21 東洋紡株式会社 担子菌酵母変異体
ITMI20120896A1 (it) 2012-05-23 2013-11-24 Bongulielmi Reto Condroitina per uso in medicina
ITMI20121316A1 (it) 2012-07-27 2014-01-28 Altergon Sa Complessi di condroitina ad assorbimento transcutaneo
CA2891552A1 (en) * 2012-11-16 2014-05-22 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Gonorrheal mtre peptides and vaccines
WO2014100920A1 (zh) * 2012-12-28 2014-07-03 安徽华恒生物工程有限公司 生产dl-丙氨酸的工程菌及利用该工程菌生产dl-丙氨酸的方法
JP6478115B2 (ja) * 2013-09-30 2019-03-06 生化学工業株式会社 タンパク質の血中滞留性の増強方法
FR3016637B1 (fr) * 2014-01-23 2020-11-27 Centre Nat Rech Scient Procede de production in vivo de glycosaminoglycane
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
EP3050973A1 (en) * 2015-01-30 2016-08-03 Jennewein Biotechnologie GmbH Fermentation process for producing monosaccharides in free form from nucleotide-activated sugars
EP3279220A4 (en) 2015-03-31 2018-12-19 Seikagaku Corporation Method for sulfating glycosaminoglycan
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
IT202000013633A1 (it) * 2020-06-08 2021-12-08 Vivatis Pharma Gmbh Processo di estrazione di una condroitina solfato da un fungo, una condroitina solfato di origine vegetale e suo uso
EP4067487A1 (en) 2021-04-01 2022-10-05 Givaudan SA Chondroitin-producing recombinant cell

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444447B1 (en) 1998-11-11 2002-09-03 The Board Of Regents Of The University Of Oklahoma Polymer grafting by polysaccharide synthases
US20030104601A1 (en) 1999-04-01 2003-06-05 Deangelis Paul L. Chondroitin synthase gene and methods of making and using same
US20060105431A1 (en) 1998-11-11 2006-05-18 Deangelis Paul L Polymer grafting by polysaccharide synthases using artificial sugar acceptors
US6235510B1 (en) 1999-08-18 2001-05-22 Smithkline Beecham Corporation ppGaNTase-T6
CA2392463C (en) 1999-11-25 2009-10-20 Yamasa Corporation Novel use of uridine diphosphate glucose 4-epimerase
DE10019881A1 (de) * 2000-04-20 2001-11-15 Gerhard Miksch Verfahren zur Überexpression und extrazellulären Produktion bakterieller Phytasen in Escherichia coli
EP1470235A4 (en) 2001-07-13 2008-05-21 Univ Oklahoma GLYCOSAMINOGLYCAN POLYMERS AND METHODS OF PREPARING AND USING THE SAME
JP4702819B2 (ja) 2001-08-01 2011-06-15 生化学工業株式会社 コンドロイチン合成酵素
JP4101548B2 (ja) 2001-08-10 2008-06-18 生化学工業株式会社 コンドロイチン合成酵素及びそれをコードするｄｎａ
DE60324797D1 (de) 2002-05-31 2009-01-02 Seikagaku Kogyo Co Ltd Chondroitinsynthetase und das enzym codierende dna
WO2003102193A1 (fr) 2002-05-31 2003-12-11 Seikagaku Corporation Chondroitine synthetase et acide nucleique codant pour cette enzyme
AU2005287397A1 (en) 2004-06-30 2006-03-30 Paul L. Deangelis Methods of selectively treating diseases with specific glycosaminoglycan polymers
ES2299284B1 (es) * 2004-11-04 2009-04-16 Universidad Pablo De Olavide Control de la expresion genica mediante el uso de un atenuador de la transcripcion.
JP2008523804A (ja) * 2004-12-16 2008-07-10 ステイヒテイング・トツプ・インステイテユト・フード・アンド・ニユトリシヨン 非病原性の非侵襲性グラム陽性細菌中での複合多糖の異種発現および分泌による、病原性グラム陽性細菌の莢膜多糖の新規効率的製造方法
KR101304921B1 (ko) * 2005-06-06 2013-09-13 피페넥스 인크. 세균 숙주 세포에서의 만니톨 유도 프로모터 시스템
EP1964924B1 (en) 2005-12-15 2015-09-30 Seikagaku Corporation Long-chain chondroitin sugar chain and method for producing the same and method for promoting synthesis of chondroitin
EP2690178B1 (en) 2006-10-03 2021-12-22 The Board Of Regents Of The University Of Oklahoma Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
KR101548139B1 (ko) * 2007-04-24 2015-08-28 세이가가쿠 고교 가부시키가이샤 콘드로이틴 생산 세균 및 콘드로이틴 생산 방법
ES2661593T3 (es) 2010-03-01 2018-04-02 Seikagaku Corporation Composiciones y métodos para producción bacteriana de condroitina
KR101855062B1 (ko) 2010-07-09 2018-05-09 그노시스 에스.피.에이. 콘드로이틴의 생물공학적 생산

Also Published As

Publication number Publication date
US9175293B2 (en) 2015-11-03
CN102869782B (zh) 2015-11-25
EP2542686B1 (en) 2018-01-03
JP2013520995A (ja) 2013-06-10
US20110244520A1 (en) 2011-10-06
ES2661593T3 (es) 2018-04-02
EP2542686A4 (en) 2014-03-26
US20140296505A1 (en) 2014-10-02
JP5875531B2 (ja) 2016-03-02
EP2542686A1 (en) 2013-01-09
US8697398B2 (en) 2014-04-15
KR101848102B1 (ko) 2018-04-11
BR112012021995A8 (pt) 2018-01-02
WO2011109438A1 (en) 2011-09-09
CN102869782A (zh) 2013-01-09
KR20130055571A (ko) 2013-05-28

Similar Documents

Publication Publication Date Title
BR112012021995A2 (pt) ''composições e métodos para a produção bacteriana de condroitina''
FR2957244B1 (fr) Implant d'arthrodese
BRPI1012525A2 (pt) composições de nanopatículas isentas de príons e métodos para sua fabricação
BR112013002170A2 (pt) manequim articulado
BR112012031033A2 (pt) composição de si--g-poliolefina e processo para fazer uma composição de si-g-poliolefina
BR112013015058A2 (pt) micro-organismos e métodos para a produção de 1,4-ciclo-hexanodimetanol
FR2956074B1 (fr) Train d'entrainement
ITUD20110032A1 (it) "macchina da fienagione"
BR112013003385A2 (pt) "composições e métodos para produzir células dentríticas"
FR2976522B1 (fr) Pneumatique munis de temoins d'usure sonores multiniveaux
IT1402691B1 (it) Tioxantoni a bassa migrabilita'
FR2965705B1 (fr) Compositions d'edulcorants
BR112013005986A2 (pt) processo para preparar uma composição derivada de estolídeo e composição derivada de estolídeo
BR112013006258A2 (pt) manequim articulado
BR112013010195A2 (pt) "empanque"
BR112013030369A2 (pt) composições de cb-183,315 e métodos relacionados
BR112013012843A2 (pt) composições e métodos para o suprimento de nutriente
DK2345695T3 (da) Elastomermodificeret termoplastisk sammensætning
EP2398692A4 (en) SEGMENTED TRACK
BR112013014678A2 (pt) composições orais e método para a produção das mesmas
BR112012029363A2 (pt) 'método para produção de 1-alquil-3-difluormetil-5-hidroxipirazóis'
FR2974584B1 (fr) Porte d'ecluse
IT1402914B1 (it) Scatola ad apertura facilitata
AU332040S (en) 90 degree single piece extrusion
FI20100297A0 (fi) Kaksiosainen kahvakuula

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SEIKAGAKU CORPORATION (JP)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL